180 related articles for article (PubMed ID: 2861170)
1. Differentiation of multiple analgesic opiate receptors.
Fürst S; Knoll J
Int J Tissue React; 1985; 7(1):69-77. PubMed ID: 2861170
[TBL] [Abstract][Full Text] [Related]
2. Quantitative studies of the antagonism by naloxone and N-cyclopropylmethyl-norazido-dihydroisomorphine (CAM) of different opiates.
Fürst S; Knoll J
Pol J Pharmacol Pharm; 1982; 34(1-3):115-25. PubMed ID: 6897745
[TBL] [Abstract][Full Text] [Related]
3. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
4. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure.
O'Callaghan JP; Holtzman SG
J Pharmacol Exp Ther; 1975 Mar; 192(3):497-505. PubMed ID: 1168252
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological actions of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1,H-4-benzazonine). 4. Antagonistic action of naloxone on eptazocine analgesia].
Nabeshima T; Yamada S; Yamaguchi K; Matsuno K; Kameyama T; Sakakibara S; Matsumoto S
Nihon Yakurigaku Zasshi; 1983 May; 81(5):411-20. PubMed ID: 6629212
[TBL] [Abstract][Full Text] [Related]
6. The effect of opiates and opiate antagonists on heat latency response in the parasitic nematode Ascaris suum.
Pryor SC; Nieto F; Henry S; Sarfo J
Life Sci; 2007 Apr; 80(18):1650-5. PubMed ID: 17363006
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the opioid activity of CAM and kappa agonists.
Furst S; Friedmann T; Kovacs A; Wagner T
NIDA Res Monogr; 1986; 75():224-7. PubMed ID: 2828975
[TBL] [Abstract][Full Text] [Related]
8. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
Hernández-Delgadillo GP; Cruz SL
Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
10. Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice.
Bredeloux P; Costentin J; Dubuc I
Behav Brain Res; 2006 Dec; 175(2):399-407. PubMed ID: 17074405
[TBL] [Abstract][Full Text] [Related]
11. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
[TBL] [Abstract][Full Text] [Related]
12. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
13. Assays for narcotic antagonist activity in rodents.
Pierson AK
Adv Biochem Psychopharmacol; 1973; 8(0):245-61. PubMed ID: 4152786
[No Abstract] [Full Text] [Related]
14. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
15. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay.
Mogil JS; Kest B; Sadowski B; Belknap JK
J Pharmacol Exp Ther; 1996 Feb; 276(2):532-44. PubMed ID: 8632319
[TBL] [Abstract][Full Text] [Related]
16. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
17. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
[TBL] [Abstract][Full Text] [Related]
18. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
19. Azidomorphines and heterogenous opiate receptors.
Fürst S; Wagner TA; Knoll J
Pol J Pharmacol Pharm; 1988; 40(6):627-34. PubMed ID: 2855884
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]